NATHAN PHARMA PRIVATE LIMITED

Nathan Pharma Private Limited, established in 2021, is a rapidly growing pharmaceutical company committed to delivering high-quality healthcare solutions under its trusted division, Arkmedcure. Our extensive product portfolio includes OMEARK-20 Capsules, PANARK-40 Injection, MOXCLARK-DUO Suspension, DYNOFLAM-AQ Injection, MEFEARK-P Junior Suspension, AROX-MZ Suspension, Arkcid-Gel Suspension, GASOMEG-O Suspension, and HEMOARK-FORTE Syrup. Manufactured in compliance with stringent quality standards, our products are formulated to ensure safety, efficacy, and patient satisfaction while addressing diverse healthcare needs.

At Nathan Pharma Private Limited, we focus on innovation, quality assurance, and ethical business practices. Our dedicated team works continuously to provide reliable pharmaceutical products that meet the expectations of healthcare professionals and patients alike. With increasing demand for quality medicines across markets, we are actively seeking distributors to strengthen our distribution network. We offer rewarding business opportunities, dependable support, and long-term growth prospects for distributors interested in partnering with a progressive and customer-focused pharmaceutical company.

Requirements to Become Distributors

Investment capacity of INR 50k-2 lakh for business operations establishment.

Minimum 100 square feet storage space maintaining product safety standards.

Basic pharmaceutical distribution knowledge with local healthcare market understanding.

Commitment towards ethical practices and long-term business growth objectives.

Benefits the Distributors Will Get

Attractive profit margins supported by growing demand for pharmaceutical products.

Consistent product availability ensuring uninterrupted supply to healthcare customers.

Marketing support helping increase brand visibility across assigned territories effectively.

Opportunity for sustainable growth through expanding healthcare distribution networks.

Product Portfolio

ESOARK-DSR Capsules

ITROARK-200 Capsules

ITROARK-100 Capsules

OMEARK-20 Capsules

PANARK-40 Injection

MOXCLARK-DUO Suspension

DYNOFLAM-AQ Injection

MEFEARK-P Junior Suspension

AROX-MZ Suspension

Arkcid-Gel Suspension

GASOMEG-O Suspension

HEMOARK-FORTE Syrup

CEFIARK-O Tablets

CEFOARK-500 Tablets

CALARK-K27 Softgel Capsules

COLDARK-P Tablets

ACERELIEVE-TH4 Tablets

AZEARK-250 Tablets

PANARK-DSR Capsules

MOXCLARK-CV Oral Suspension

MOXCLARK-DUO Oral Suspension

CEFIARK-200 Dispersible Tablets

ACERELIEVE-SP Tablets

DOXMEDARK-LB Capsules

AMYARK-500 Injection

Laxoark Suspension

ACERELIEVE-MR Tablets

AZEARK-500 Tablets

ACERELIEVE-TH4 Tablets

CEFTOARK-S Injection

Features of the Products

High quality formulations

Safe effective medications

Stringent quality standards

Reliable therapeutic performance

Patient-focused healthcare solutions

Strengths of the Company

Quality-focused manufacturing adhering to stringent pharmaceutical industry standards consistently.

Diverse healthcare portfolio addressing multiple therapeutic and patient requirements.

Customer-centric approach emphasizing reliability, trust, and long-term relationships.

Dedicated support system assisting distributors in achieving business success.